NIH discontinues tenofovir vaginal gel in 'VOICE' HIV prevention study
A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational ...
Nov 28, 2011
0
0